Drug Profile
S 444823
Alternative Names: S-444823Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Shionogi
- Class Antipruritics; Skin disorder therapies
- Mechanism of Action Cannabinoid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Atopic dermatitis
Most Recent Events
- 01 Jan 2010 Phase-II clinical trials in Atopic dermatitis in Japan (Topical) (JapicCTI100996)